Literature DB >> 758598

Viral hepatitis, type B. Studies on natural history and prevention re-examined.

S Krugman, L R Overby, I K Mushahwar, C M Ling, G G Frösner, F Deinhardt.   

Abstract

Frozen serial serum specimens obtained from past studies on the natural history and prevention of Type B hepatitis in children were retested by radioimmunoassay for the following markers of hepatitis B infection: hepatitis B surface antigen (HBsAg) and antibody (anti-HBs), hepatitis B e antigen (HBeAg) and antibody (anti-HBe), and antibody to hepatitis B core antigen (anti-HBc). The interval between exposure and evidence of viremia (HBsAg) was as short as six days. HBsAg and HBeAg persisted for two to five months and occasionally for more than one year after recovery. After the disappearance of their respective antigens, anti-HBc and anti-HBs persisted for more than seven years and anti-HBe for one to two years. Treatment with hepatitis B immune globulin after exposure induced complete or partial protection or prolongation of the incubation period. Administration of heat-inactivated hepatitis B virus, MS-2 strain, to 29 children induced an inapparent infection in three, characterized by a transient appearance of HBsAg and HBeAg, and the persistence of anti-HBc, anti-HBe and anti-HBs for more than two years.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758598     DOI: 10.1056/NEJM197901183000301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  45 in total

1.  Cost-effective evaluation of acute viral hepatitis.

Authors:  A Ahmed; E B Keeffe
Journal:  West J Med       Date:  2000-01

2.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.

Authors:  Masatoshi Ishigami; Hideya Kamei; Taro Nakamura; Yoshiaki Katano; Hisami Ando; Tetsuya Kiuchi; Hidemi Goto
Journal:  J Gastroenterol       Date:  2010-09-11       Impact factor: 7.527

Review 4.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

5.  Cytotoxicity of human peripheral blood T-lymphocyte clones activated by hepatitis B virus surface antigen.

Authors:  A A Hakim
Journal:  Experientia       Date:  1985-12-15

6.  Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg).

Authors:  H E Blum; G Dölken; W Gerok
Journal:  Klin Wochenschr       Date:  1979-10-15

Review 7.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

8.  Attempted treatment of fulminant viral hepatitis with human fibroblast interferon.

Authors:  F Milazzo; M Galli; P G Fassio; A Cargnel; A Pugliese; P A Tovo; G M Vigevani; R Esposito; A Lazzarin; F Caredda
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

9.  Arthritis as the main or only symptom of hepatitis B infection.

Authors:  C Pease; A Keat
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

Review 10.  Hepatitis B virus infection. Current concepts of chronicity and immunity.

Authors:  G N Vyas; H E Blum
Journal:  West J Med       Date:  1984-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.